Key result
Percutaneous coronary intervention was associated with significantly lower odds of 30-day readmission (OR 0.63) and 30-day mortality (OR 0.60) compared to no intervention, despite increasing admission costs.
Why the study?
CAD requiring PCI has a wide spectrum of presentations, and the cost of admission and PCI stratified by CAD presentation types had not been reviewed.
Does percutaneous coronary intervention improve 30-day readmission and mortality in patients undergoing coronary angiogram for various CAD presentations?
Cohort (n=6,403)
No
Does percutaneous coronary intervention improve 30-day readmission and mortality in patients undergoing coronary angiogram for various CAD presentations?
In patients undergoing coronary angiography, PCI is associated with lower 30-day mortality and readmission rates but higher admission costs across various CAD presentations compared to no PCI.
PCI may lower short-term events after angiography in CAD; leaves open net benefit and causality pending randomized trials.
Introduction Atherosclerotic coronary artery disease (CAD) is the major cause of mortality in the USA. CAD requiring percutaneous coronary intervention (PCI) can have a wide spectrum of presentations. We reviewed the cost of admission and PCI at the tertiary care center stratified for different CAD presentation types. Methods We performed a retrospective study of 7,389 patients undergoing coronary angiogram at our facility from 2015 to 2017. Patients were selected from CathPCI registry. Chart review was done for readmission and death data. Cost data were provided by the finance department. Patients going for coronary artery bypass surgery (CABG) were excluded. We split the patients based on their need for PCI. Cost analysis was based on CAD presentation types (No symptoms, atypical symptoms, stable angina, unstable angina, NSTEMI [non-ST segment elevation myocardial infarction], STEMI [ST-segment elevation myocardial infarction]). Adjusted linear regression was run for the outcomes. Primary outcomes were 30-day readmission and death. The secondary outcome was cost of admission. Results The final sample size was 6,403. The mean age was 65.6 years (SD: 12.5; male: 63.8%). 2444 required PCI (38%; p < 0.001). PCI group had lower mean age (62.5 years; SD: 12.3, p<0.001) with lower BMI (30.6 vs 31.1, p=0.015). PCI group had significantly lower odds for 30-day readmission (OR: 0.63; CI: 0.45-0.89; p=0.009) and 30-day mortality (OR:0.60; CI: 0.41-0.89; p = 0.011). A severe presentation increased the odds of getting PCI. Cost of admission was higher in all groups receiving PCI. Conclusions PCI group had better 30-day readmission and mortality rates. PCI increases the cost of admission in all CAD types.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2021) conducted a cohort in Coronary Artery Disease (n=6,403). Percutaneous coronary intervention (PCI) vs. No PCI was evaluated on 30-day readmission (OR 0.63, 95% CI 0.45-0.89, p=0.009). Percutaneous coronary intervention was associated with significantly lower odds of 30-day readmission (OR 0.63) and 30-day mortality (OR 0.60) compared to no intervention, despite increasing admission costs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: